Skip to main content

Advertisement

Log in

Oncogenic protein tyrosine kinases

Dysfunction of the RET receptor in human cancer

  • Multi-author Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a single gene that causes different types of human cancer when targeted by different genetic alterations. Like other receptor tyrosine kinases, once activated, RET recruits a variety of signaling molecules that mediate biological responses. Here we review data on the signaling pathways that lead to RET-mediated cell transformation and recent evidence that manipulation of RET holds promise for thyroid cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Santoro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santoro, M., Carlomagno, F., Melillo, R.M. et al. Oncogenic protein tyrosine kinases. CMLS, Cell. Mol. Life Sci. 61, 2954–2964 (2004). https://doi.org/10.1007/s00018-004-4276-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-004-4276-8

Key words.

Navigation